{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T23:31:33Z","timestamp":1795131093480,"version":"4.10.3"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2023.284868","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:26:57Z","timestamp":1708576017000},"page":"3031-3036","source":"Crossref","is-referenced-by-count":5,"title":["&lt;i&gt;TP53&lt;\/i&gt; DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification"],"prefix":"10.3324","volume":"109","author":[{"given":"Gaia","family":"Martire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Lovisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Bertolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Boaretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Salviati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Mussolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"66221","doi-asserted-by":"crossref","unstructured":"Burkhardt B, Taj M, Garnier N. Treatment and outcome analysis of 639 relapsed non-Hodgkin lymphomas in children and adolescents and resulting treatment recommendations. Cancers. 2021; 13(9):2075.","DOI":"10.3390\/cancers13092075"},{"key":"66222","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Anderson JR. Rituximab and FAB\/ LMB 96 chemotherapy in children with Stage III\/IV B-cell non-Hodgkin lymphoma: a Children\u2019s Oncology Group report. Leukemia. 2013; 27(5):1174-1177.","DOI":"10.1038\/leu.2012.255"},{"key":"66223","doi-asserted-by":"crossref","unstructured":"Goldman S, Smith L, Galardy P. Rituximab with chemotherapy in children and adolescents with central nervous system and\/or bone marrow-positive Burkitt lymphoma\/ leukaemia: a Children\u2019s Oncology Group Report. Br J Haematol. 2014; 167(3):394-401.","DOI":"10.1111\/bjh.13040"},{"key":"66224","doi-asserted-by":"crossref","unstructured":"Minard-Colin V, Aup\u00e9rin A, Pillon M. Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N Engl J Med. 2020; 382(23):2207-2219.","DOI":"10.1056\/NEJMoa1915315"},{"key":"66225","doi-asserted-by":"crossref","unstructured":"Pillon M, Mussolin L, Carraro E. Detection of prognostic factors in children and adolescents with Burkitt and diffuse large B-cell lymphoma treated with the AIEOP LNH-97 protocol. Br J Haematol. 2016; 175(3):467-475.","DOI":"10.1111\/bjh.14240"},{"key":"66226","doi-asserted-by":"crossref","unstructured":"Ehrhardt MJ, Chen Y, Sandlund JT. Late health outcomes after contemporary lymphome malin de Burkitt therapy for mature B-cell non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2019; 37(28):2556-2570.","DOI":"10.1200\/JCO.19.00525"},{"key":"66227","doi-asserted-by":"crossref","unstructured":"Attarbaschi A, Carraro E, Ronceray L. Second malignant neoplasms after treatment of non-Hodgkin\u2019s lymphoma-a retrospective multinational study of 189 children and adolescents. Leukemia. 2021; 35(2):534-549.","DOI":"10.1038\/s41375-020-0841-x"},{"key":"66228","doi-asserted-by":"crossref","unstructured":"Newman AM, Zaka M, Zhou P. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma. Leukemia. 2022; 36(3):781-789.","DOI":"10.1038\/s41375-021-01444-6"},{"key":"66229","doi-asserted-by":"crossref","unstructured":"Burkhardt B, Michgehl U, Rohde J. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022; 13(1):3881.","DOI":"10.1038\/s41467-022-31355-8"},{"key":"66230","doi-asserted-by":"crossref","unstructured":"Kanakry JA, Li H, Gellert LL. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood. 2013; 121(18):3547-3553.","DOI":"10.1182\/blood-2012-09-454694"},{"key":"66231","doi-asserted-by":"crossref","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S, Crown J. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2022; 79:58-67.","DOI":"10.1016\/j.semcancer.2020.07.005"},{"key":"66232","doi-asserted-by":"crossref","unstructured":"Mussolin L, Pillon M, d\u2019Amore ESG. Minimal disseminated disease in high-risk Burkitt\u2019s lymphoma identifies patients with different prognosis. J Clin Oncol. 2011; 29(13):1779-1784.","DOI":"10.1200\/JCO.2010.32.8161"},{"key":"66233","doi-asserted-by":"crossref","unstructured":"Mussolin L, Lovisa F, Gallingani I. Minimal residual disease analysis in childhood mature B-cell leukaemia\/lymphoma treated with AIEOP LNH-97 protocol with\/without anti-CD20 administration. Br J Haematol. 2020; 189(3):e108-e111.","DOI":"10.1111\/bjh.16531"},{"key":"66234","doi-asserted-by":"crossref","unstructured":"Lovisa F, Mussolin L, Corral L. IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt\u2019s lymphoma and mature B-ALL MRD analysis. Lab Invest. 2009; 89(10):1182-1186.","DOI":"10.1038\/labinvest.2009.81"},{"key":"66235","unstructured":"Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980; 7(3):332-339."}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284868\/76633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.284868\/77445","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11473\/76633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:45Z","timestamp":1794045945000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.284868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":15,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.284868","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}